Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Virology Journal|April 4, 2018
The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-β/Smad signaling pathwayMeng-Lan Wang, Dong-Bo Wu, Ya-Chao Tao, et al.
Journal of Viral Hepatitis|November 1, 2018
Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective studyDong-Bo Wu, Wei Jiang, Yong-Hong Wang, et al.
Scandinavian Journal of Gastroenterology|September 8, 2017
Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapyMeng-Lan Wang, En-Qiang Chen, Chuan-Min Tao, et al.
Clinics and Research in Hepatology and Gastroenterology|December 19, 2016
Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis BLi-Bo Yan, Xia Zhu, Lang Bai, et al.
Molecular Medicine Reports|July 14, 2015
Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivoXiao-Hua Leng, En-Qiang Chen, Ling-Yao Du, et al.
Virology Journal|October 5, 2018
Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort studyYa-Chao Tao, Rong Deng, Meng-Lan Wang, et al.
Viral Immunology|April 23, 2016
Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg SeroconversionMeng-Lan Wang, Qiao-Ling Zhou, En-Qiang Chen, et al.
Plasmid|November 27, 2010
Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancerEn-Qiang Chen, Xue-Qin Song, Ya-Li Wang, et al.
Journal of Viral Hepatitis|February 13, 2020
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatmentYa-Chao Tao, Meng-Lan Wang, Dong-Mei Zhang, et al.
Journal of Medical Virology|October 15, 2019
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavirYong-Hong Wang, Juan Liao, Dong-Mei Zhang, et al.
Pageof 11